Boundless Bio, Inc. Common Stock (BOLD)
USD 1.21
(1.68%)
USD 1.21
(1.68%)
| Breakdown | 2023 | 2022 | 2021 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -46.85 Million | -39.59 Million | -23.24 Million | -107.97 Million | -84.5 Million | -49.01 Million |
| Net Income | -49.43 Million | -45.9 Million | -25.21 Million | -128.82 Million | -90.23 Million | -59.66 Million |
| Depreciation & Amortization | 957 Thousand | 942 Thousand | 682 Thousand | 7.45 Million | 3.74 Million | 1.57 Million |
| Deferred income taxes | -3.3 Million | 503 Thousand | 536 Thousand | - | 2.24 Million | -95.2 Million |
| Stock-based compensation | 3.33 Million | 2.29 Million | 1.15 Million | - | 6.88 Million | 2 Million |
| Change in working capital | -799 Thousand | 866 Thousand | -837 Thousand | 276.62 Million | 23.42 Million | 95.2 Million |
| Other non-cash items | 2.38 Million | 1.7 Million | 423 Thousand | -279.73 Million | -30.56 Million | 7.06 Million |
| Investing Cash Flow | -38.26 Million | 16.13 Million | -59.28 Million | -185.04 Million | -33.43 Million | -62.04 Million |
| Investments in PPE | -633 Thousand | -1.06 Million | -2.03 Million | -11.6 Million | -7.55 Million | -16.65 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | -160.12 Million | -42.59 Million | -77.49 Million | -382.02 Million | -152.71 Million | -104.03 Million |
| Sales/Maturities of investments | 122.49 Million | 59.79 Million | 20.23 Million | 208.58 Million | 126.82 Million | 58.62 Million |
| Other Investing Activities | - | - | - | - | - | 16 Thousand |
| Financing Cash Flow | 97.89 Million | 126 Thousand | 105.52 Million | 398.46 Million | 120.55 Million | 75.36 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | -144.34 Million | -38.96 Million | -36.35 Million |
| Common Stock Issuance | 97.89 Million | 126 Thousand | 105.52 Million | 14.6 Million | 39.1 Million | 75.2 Million |
| Other Financing Activities | 97.89 Million | - | - | 528.21 Million | 120.42 Million | 36.51 Million |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 1.66 Million | 1.91 Million | 1.22 Million | 4.08 Million | 686 Thousand | -671 Thousand |
| Inventory | - | - | - | - | - | - |
| Other working capital | -2.46 Million | -1.04 Million | -2.06 Million | 272.54 Million | 22.73 Million | 671 Thousand |
| Cash at beginning of period | 11.48 Million | 34.82 Million | 11.82 Million | 38.91 Million | 36.35 Million | 72.05 Million |
| Cash at end of period | 24.26 Million | 11.48 Million | 34.82 Million | 144.34 Million | 38.96 Million | 36.35 Million |
| Capital Expenditure | -633 Thousand | -1.06 Million | -2.03 Million | -11.6 Million | -7.55 Million | -16.65 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 12.78 Million | -23.33 Million | 22.99 Million | 105.43 Million | 2.6 Million | -35.69 Million |
| Free Cash Flow | -47.48 Million | -40.66 Million | -25.28 Million | -119.58 Million | -92.06 Million | -65.66 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -16.97 Million | -15.43 Million | -12.14 Million | -49.43 Million | -13.17 Million | -12.39 Million |
| Depreciation & Amortization | 265 Thousand | 263 Thousand | 247 Thousand | 957 Thousand | 235 Thousand | 238 Thousand |
| Deferred income taxes | - | - | -1.2 Million | -3.3 Million | -1.28 Million | - |
| Stock-based compensation | 2.13 Million | 1.32 Million | 911 Thousand | 3.33 Million | 883 Thousand | 927 Thousand |
| Change in working capital | -587 Thousand | -1.58 Million | -180 Thousand | -799 Thousand | 544 Thousand | 501 Thousand |
| Other non-cash items | 345 Thousand | 1.71 Million | 687 Thousand | 2.38 Million | 602 Thousand | 538 Thousand |
| Investing Cash Flow | -68.19 Million | 18.13 Million | 15.81 Million | -38.26 Million | -7.71 Million | -68.52 Million |
| Investments in PPE | -1.5 Million | -83 Thousand | -268 Thousand | -633 Thousand | -151 Thousand | -128 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | -103.62 Million | -21.02 Million | -27.42 Million | -160.12 Million | -35.31 Million | -87.39 Million |
| Sales/Maturities of investments | 36.94 Million | 39.24 Million | 43.5 Million | 122.49 Million | 27.75 Million | 19 Million |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | 90.64 Million | -924 Thousand | -1.38 Million | 97.89 Million | -447 Thousand | 99.69 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 90.64 Million | -924 Thousand | -1.38 Million | 97.89 Million | - | - |
| Other Financing Activities | -2.35 Million | -983 Thousand | -1.38 Million | 97.89 Million | - | - |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | 1.24 Million | -210 Thousand | 549 Thousand | 1.66 Million | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | -1.83 Million | -1.37 Million | -729 Thousand | -2.46 Million | - | - |
| Cash at beginning of period | 25.14 Million | 23.7 Million | 21.52 Million | 11.48 Million | 41.87 Million | 21.59 Million |
| Cash at end of period | 31.36 Million | 25.14 Million | 24.26 Million | 24.26 Million | 21.52 Million | 41.87 Million |
| Capital Expenditure | -1.5 Million | -83 Thousand | -268 Thousand | -633 Thousand | -151 Thousand | -128 Thousand |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | 6.22 Million | 1.43 Million | 2.74 Million | 12.78 Million | -20.35 Million | 20.28 Million |
| Free Cash Flow | -17.74 Million | -15.85 Million | -11.95 Million | -47.48 Million | -12.34 Million | -11.01 Million |
603629
601825
PTBL
STARPAPER
EDAC
DIGIGR